A vast array of hormones, upon binding to their cognate receptors on the cell surface, cause an increase in intracellular cAMP, the principal target of which is cAMP-dependent protein kinase (PKA). This system constitutes a major signaling pathway by which animal physiology is regulated. The Walsh inhibitor, or PKI, is a potent and highly specific inhibitor of PKA that was discovered nearly 30 years ago in skeletal muscle. A second inhibitor, referred to as testis PKI, was subsequently identified. It is now known that these two isoforms of PKI are encoded by unique genes, and are expressed in a distinct, but overlapping, assembly of tissues. Importantly, both are expressed in testis, where they are differentially regulated. Despite extensive biochemical characterization, including the recent discovery that PKI exhibits a nuclear export activity, little is known about the physiological role of PKI. The goal of this project is to examine the importance of the inhibitory and nuclear export activities of PKI in male reproductive function. This project uses embryonic stem cell mediated gene targeting technology to develop mouse strains carrying either an inactivating mutation in each PKI gene or a subtle mutation that inactivates the nuclear export signal of PKI. The phenotypic and biochemical outcome of these mutations will be assessed. Preliminary studies will identify which of the cell types (germ cells vs. non-germ cells) of the testis express the two PKI isoforms, and will provide the basis for subsequent analysis of the mutant mouse lines. In addition, the nuclear export signal of PKI will be identified by transient transfection studies in cultured cells in preparation for the gene targeting in mice. These studies will identify defects in testicular function resulting from a loss of, or a functional alteration in PKI, as well as provide PKI-deficient mice for future studies on the role of PKI in non- reproductive tissues. It is anticipated that these molecular genetic approaches will provide a wealth of novel information about the physiological function of PKI, and will contribute significantly to our overall understanding of the cAMP second messenger system in male reproduction and fertility, an area of global concern.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HD033057-05
Application #
6164904
Study Section
Biochemistry Study Section (BIO)
Program Officer
Taymans, Susan
Project Start
1996-03-01
Project End
2002-02-28
Budget Start
2000-03-01
Budget End
2002-02-28
Support Year
5
Fiscal Year
2000
Total Cost
$92,454
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Belyamani, M; Gangolli, E A; Idzerda, R L (2001) Reproductive function in protein kinase inhibitor-deficient mice. Mol Cell Biol 21:3959-63
Gangolli, E A; Belyamani, M; Muchinsky, S et al. (2000) Deficient gene expression in protein kinase inhibitor alpha Null mutant mice. Mol Cell Biol 20:3442-8
Wiley, J C; Wailes, L A; Idzerda, R L et al. (1999) Role of regulatory subunits and protein kinase inhibitor (PKI) in determining nuclear localization and activity of the catalytic subunit of protein kinase A. J Biol Chem 274:6381-7